Workflow
Henan Jindan Lactic Acid Technology (300829)
icon
Search documents
金丹科技(300829) - 董事会决议公告
2025-04-20 07:45
| 证券代码:300829 | 证券简称:金丹科技 | 公告编号:2025-021 | | --- | --- | --- | | 债券代码:123204 | 债券简称:金丹转债 | | 河南金丹乳酸科技股份有限公司 第五届董事会第二十三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 河南金丹乳酸科技股份有限公司(以下简称公司)第五届董事会第二十三次会议 于 2025 年 4 月 17 日上午 9:00 以现场结合通讯方式在公司会议室召开,会议通知于 2025 年 4 月 7 日以电话及电子邮件方式发出。 本次会议由公司董事长张鹏先生主持。本次会议应出席董事 7 名,实际参加董事 7 名,其中余龙、张复生、赵永德以通讯表决方式出席会议。公司监事会成员、高级管 理人员列席了会议。本次会议的召集和召开符合国家有关法律、法规及《公司章程》 的规定,决议合法有效。 二、董事会会议审议情况 经与会董事充分讨论,本次会议审议了如下议案: 1.审议通过《关于公司<2024 年度总经理工作报告>的议案》。 公司总经理根据 2024 年度 ...
金丹科技(300829) - 关于2024年度利润分配的预案公告
2025-04-20 07:45
河南金丹乳酸科技股份有限公司 | 证券代码:300829 | 证券简称:金丹科技 | 公告编号:2025-023 | | --- | --- | --- | | 债券代码:123204 | 债券简称:金丹转债 | | 关于 2024 年度利润分配的预案公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 一、 审议程序 河南金丹乳酸科技股份有限公司(以下简称公司)于 2025 年 4 月 17 日召开 第五届董事会第二十三次会议、第五届监事会第十八次会议,审议通过了《关于 2024 年度利润分配的预案》,该议案尚需提交公司 2024 年度股东大会审议。现 将具体情况公告如下: 1.董事会审议情况 公司第五届董事会第二十三次会议以 7 票同意,0 票反对,0 票弃权审议通 过了《关于 2024 年度利润分配的预案》,公司 2024 年度利润分配方案符合公司 的利润分配政策、利润分配计划、股东长期回报规划以及做出的相关承诺,具有 合法性、合规性、合理性,能够满足公司未来经营发展的需要,有利于公司持续 稳定发展。并同意将该预案提交公司 2024 年度股东大会审议。 ...
金丹科技(300829) - 2024 Q4 - 年度财报
2025-04-20 07:36
Financial Performance - The company reported a significant decline in net profit attributable to shareholders, with a large asset impairment loss impacting the results compared to the same period last year [3]. - The company's operating revenue for 2024 was ¥1,505,361,017.89, representing a 6.15% increase compared to ¥1,418,129,886.71 in 2023 [21]. - The net profit attributable to shareholders for 2024 decreased by 56.01% to ¥37,491,241.90 from ¥85,230,195.58 in 2023 [21]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥16,085,777.11, down 71.51% from ¥56,466,381.25 in 2023 [21]. - The basic earnings per share for 2024 was ¥0.20, down 57.45% from ¥0.47 in 2023 [21]. - The weighted average return on equity for 2024 was 2.15%, a decrease of 3.16% from 5.31% in 2023 [21]. - The company reported a significant loss in the fourth quarter with a net profit of -¥64,066,240.70, contrasting with positive profits in the first three quarters [23]. - The net cash flow from operating activities increased significantly by 634.96% to ¥260,510,753.53 compared to ¥35,445,789.43 in 2023 [21]. - The total assets at the end of 2024 were ¥3,461,256,531.96, a 1.75% increase from ¥3,401,570,403.32 at the end of 2023 [21]. - The net assets attributable to shareholders increased by 7.94% to ¥1,839,529,850.94 from ¥1,704,257,520.83 at the end of 2023 [21]. Business Strategy and Development - The company is actively extending its main business into the biodegradable materials circular industry chain, including products such as lactic acid, lactic acid salts, and biodegradable materials [4]. - The company is a leading enterprise in the research, production, and sales of lactic acid and its derivatives, exporting to over 90 countries [71]. - The company focuses on developing efficient, energy-saving, and environmentally friendly production technologies for lactic acid [71]. - The company is actively developing downstream market applications to enhance market demand and leverage economies of scale [82]. - The company is engaged in multiple R&D projects, including clean production technology for low pH strains and high-performance resin research for biodegradable materials [80]. - The company aims to optimize production processes and reduce PLA production costs to facilitate the replacement of traditional plastics [82]. - The company has established a comprehensive sales model, combining direct sales and distributor sales for both domestic and international markets [89]. - The company has a strong customer resource advantage, with products sold in over 90 countries and regions, including partnerships with major industry players [96]. Market Trends and Outlook - The lactic acid market is experiencing increased demand in the food and pharmaceutical sectors due to rising food safety standards and advancements in medical technology [38]. - The outlook for 2025 suggests improved corn demand due to lower raw material costs and better profit expectations for processing and breeding enterprises [37]. - The global lactic acid market is dominated by North America (45%) and the Asia-Pacific region (over 19%), with significant growth driven by rising consumer demand in China and India [41]. - The demand for polylactic acid (PLA) is expected to grow significantly, outpacing traditional sectors like food and beverage, leading to increased competition in the lactic acid market [45]. - The biodegradable materials industry is expected to grow due to increasing environmental concerns and the depletion of fossil resources, with a focus on applications in packaging and agricultural films [157]. Regulatory Environment - In 2024, the Henan Provincial Government implemented regulations to prohibit and restrict the production, sale, and use of non-degradable disposable plastic products, promoting the adoption of biodegradable materials [47]. - The National Development and Reform Commission revised the "Guidance Catalog for Industrial Structure Adjustment" in 2024, encouraging 352 items and restricting 231 items related to bio-based and biodegradable materials [48]. - New regulations on food additives in 2024 may create opportunities for lactic acid to replace restricted substances, driving future demand growth [46]. Research and Development - The company is currently in the pilot testing phase for a new application of lactic acid in meat products, aiming to deepen product development [114]. - The company is developing new fermentation technology aimed at reducing fermentation costs and improving quality, currently in the pilot testing phase [117]. - The company is working on high-performance biodegradable PLA materials to enhance mechanical properties and reduce production costs, aiming for industrial application [116]. - The number of R&D personnel increased to 235 in 2024, up 21.76% from 193 in 2023, with a proportion of 17.51% of total employees [117]. - R&D investment amounted to ¥56,808,227.28 in 2024, representing 3.77% of operating revenue, slightly down from 3.79% in 2023 [117]. Financial Management - The company maintains an independent financial department, adhering to accounting laws and regulations, with a separate financial accounting system and independent bank accounts, ensuring no shared accounts with the controlling shareholder [181]. - The company has implemented a comprehensive risk management system for its hedging activities, including internal controls and regular audits [136]. - The company plans to align its hedging activities with its operational needs to minimize price fluctuation risks [136]. - The company has not engaged in speculative derivative investments during the reporting period [137]. Corporate Governance - The company has a structured remuneration decision process that requires approval from the board and submission to the shareholders' meeting [195]. - The company maintains transparency in its remuneration practices, ensuring that all payments are documented and reported [195]. - The board of directors held a total of 11 meetings during the reporting period, with all members present at each meeting [198]. - No objections were raised by the directors regarding company matters during the reporting period [200].
金丹科技(300829) - 关于使用闲置募集资金及自有资金进行现金管理的进展公告
2025-04-13 08:30
| 证券代码:300829 | 证券简称:金丹科技 | 公告编号:2025-018 | | --- | --- | --- | | 债券代码:123204 | 债券简称:金丹转债 | | 河南金丹乳酸科技股份有限公司 关于使用闲置募集资金及自有资金进行现金管理的 进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 河南金丹乳酸科技股份有限公司(以下简称公司)于2024年7月22日召开第 五届董事会第十六次会议和第五届监事会第十三次会议审议通过了《关于使用闲 置募集资金进行现金管理的议案》《关于使用闲置自有资金进行委托理财的议案》 等议案,同意公司在确保不影响正常运营和资金安全的前提下,使用闲置募集资 金不超过人民币4亿元(含本数)进行现金管理,用于购买投资期限不超过12个 月的安全性高、流动性好的保本型投资产品,投资产品不得进行质押;同意公司 及合并报表范围内的子公司使用总额度不超过人民币1.5亿元(含本数)的闲置自 有资金进行委托理财,用于购买银行、证券公司等金融机构发行的安全性高、流 动性好的各类理财产品,有效期自公司董事会审议通过之日起不超过12个 ...
政策利好驱动农业股再度强势,新赛股份4连板,关注两条投资主线
Di Yi Cai Jing· 2025-04-09 02:07
Group 1 - The agricultural sector is experiencing strong performance, with multiple stocks such as XinSai Co., WanXiang DeNong, BeiDaHuang, and QiuLe Seed Industry hitting the daily limit, while others like JinDan Technology and KangNong Seed Industry have risen over 10% [1][2] - Specific stock performance includes QiuLe Seed Industry up by 29.98% to 28.57, KangNong Seed Industry up by 23.67% to 54.66, and JinDan Technology up by 16.50% to 17.70 [2] Group 2 - The Central Committee of the Communist Party and the State Council have issued a plan for building a strong agricultural nation by 2035, aiming for significant progress by 2027 and modernization of rural areas [3] - The plan emphasizes the need for advanced agricultural machinery, highlighting the demand for high-performance and intelligent agricultural equipment, particularly in grain production [3] - The plan also includes upgrading agricultural machinery and promoting the integration of agricultural machinery and agronomy to enhance efficiency and productivity [3] Group 3 - Pacific Securities highlights the defensive attributes of the agricultural sector amid trade tariffs, recommending investment in the planting industry chain related to soybeans and corn, as well as livestock sectors related to pork and poultry [4] - The investment strategy focuses on sectors with strong recovery potential, such as dairy farming and poultry farming, which are experiencing capacity reduction and price reversal expectations [4] - The pet food sector is also identified as a value investment opportunity due to its sustained high demand and overseas production capabilities [4]
金丹科技(300829) - 河南金丹乳酸科技股份有限公司关于股份回购进展的公告
2025-04-02 10:42
| 证券代码:300829 | 证券简称:金丹科技 公告编号:2025-015 | | --- | --- | | 债券代码:123204 | 债券简称:金丹转债 | 河南金丹乳酸科技股份有限公司 关于股份回购进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 河南金丹乳酸科技股份有限公司(以下简称公司)于2025年1月7日召开第五 届董事会第二十二次会议,审议通过了《关于回购公司股份方案的议案》,同意 公司使用自有资金和股份回购专项贷款以集中竞价交易方式回购公司已发行的 人民币普通股(A股)股票(以下简称本次回购),回购股份后续将用于实施员工 持股计划或股权激励。本次回购的资金总额不低于人民币4,000万元且不超过人 民币7,000万元(均含本数),回购价格不超过人民币28.11元/股(含本数)。 本次回购股份的实施期限自董事会审议通过本次回购股份方案之日起十二 个月内。具体内容详见公司于2025年1月8日、2025年1月15日刊登在巨潮资讯网 (www.cninfo.com.cn)的《关于回购公司股份方案暨取得金融机构股票回购专项 贷款承诺函的公告 ...
金丹科技(300829) - 关于2025年第一季度可转换公司债券转股情况的公告
2025-04-02 10:42
| 证券代码:300829 | 证券简称:金丹科技 | 公告编号:2025-016 | | --- | --- | --- | | 债券代码:123204 | 债券简称:金丹转债 | | 河南金丹乳酸科技股份有限公司 关于 2025 年第一季度可转换公司债券转股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 特别提示: 1.金丹转债(债券代码:123204)转股期限为 2024 年 1 月 19 日至 2029 年 7 月 12 日,最新有效的转股价格为人民币 14.98 元/股。 2.2025 年第一季度,共有 23,423 张"金丹转债"完成转股(票面金额共计 234.23 万元人民币),合计转成 156,339 股"金丹科技"股票(股票代码:300829)。 截至 2025 年第一季度末,合计共有 1,765,444 张"金丹转债"完成转股(票面 金额共计 17,654.44 万元人民币),合计转成 11,747,171 股"金丹科技"股票(股 票代码:300829)。 3.截至 2025 年第一季度末,河南金丹乳酸科技股份有限公司(以下简称 ...
金丹科技(300829) - 关于使用闲置募集资金及自有资金进行现金管理的进展公告
2025-03-18 07:50
| 证券代码:300829 | 证券简称:金丹科技 | 公告编号:2025-014 | | --- | --- | --- | | 债券代码:123204 | 债券简称:金丹转债 | | 河南金丹乳酸科技股份有限公司 关于使用闲置募集资金及自有资金进行现金管理的 进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 河南金丹乳酸科技股份有限公司(以下简称公司)于2024年7月22日召开第 五届董事会第十六次会议和第五届监事会第十三次会议审议通过了《关于使用闲 置募集资金进行现金管理的议案》《关于使用闲置自有资金进行委托理财的议案》 等议案,同意公司在确保不影响正常运营和资金安全的前提下,使用闲置募集资 金不超过人民币4亿元(含本数)进行现金管理,用于购买投资期限不超过12个 月的安全性高、流动性好的保本型投资产品,投资产品不得进行质押;同意公司 及合并报表范围内的子公司使用总额度不超过人民币1.5亿元(含本数)的闲置自 有资金进行委托理财,用于购买银行、证券公司等金融机构发行的安全性高、流 动性好的各类理财产品,有效期自公司董事会审议通过之日起不超过12个 ...
金丹科技(300829) - 河南金丹乳酸科技股份有限公司关于股份回购进展的公告
2025-03-03 09:16
| 证券代码:300829 | 证券简称:金丹科技 公告编号:2025-013 | | --- | --- | | 债券代码:123204 | 债券简称:金丹转债 | 河南金丹乳酸科技股份有限公司 关于股份回购进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 河南金丹乳酸科技股份有限公司(以下简称公司)于2025年1月7日召开第五 届董事会第二十二次会议,审议通过了《关于回购公司股份方案的议案》,同意 公司使用自有资金和股份回购专项贷款以集中竞价交易方式回购公司已发行的 人民币普通股(A股)股票(以下简称本次回购),回购股份后续将用于实施员工 持股计划或股权激励。本次回购的资金总额不低于人民币4,000万元且不超过人 民币7,000万元(均含本数),回购价格不超过人民币28.11元/股(含本数)。 本次回购股份的实施期限自董事会审议通过本次回购股份方案之日起十二 个月内。具体内容详见公司于2025年1月8日、2025年1月15日刊登在巨潮资讯网 (www.cninfo.com.cn)的《关于回购公司股份方案暨取得金融机构股票回购专项 贷款承诺函的公告 ...
金丹科技(300829) - 国金证券股份有限公司关于河南金丹乳酸科技股份有限公司2024年度持续督导之定期现场检查报告
2025-02-19 08:24
国金证券股份有限公司 关于河南金丹乳酸科技股份有限公司 2024 年度持续督导之定期现场检查报告 | 保荐人名称:国金证券股份有限公司 | 被保荐公司简称:金丹科技 | | | --- | --- | --- | | 保荐代表人姓名:朱垚鹏 | 联系电话:021-68826021 | | | 保荐代表人姓名:解明 | 联系电话:021-68826021 | | | 现场检查人员姓名:解明、宋乐真 | | | | 现场检查对应期间:2024 年度 | | | | 现场检查时间:2025 年 2 月 13-14 日 | | | | 一、现场检查事项 | 现场检查意见 | | | (一)公司治理 | 是 否 | 不适用 | | 现场检查手段(包括但不限于本指引第三十三条所列): | | | | 1.公司章程和公司治理制度是否完备、合规 | √ | | | 2.公司章程和三会规则是否得到有效执行 | √ | | | 3.三会会议记录是否完整,时间、地点、出席人员及会 | √ | | | 议内容等要件是否齐备,会议资料是否保存完整 | | | | 4.三会会议决议是否由出席会议的相关人员签名确认 | √ | | | 5 ...